3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
15
Neoplasm Metastasis
5
Ovarian Neoplasms
3
Endometrial Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Neoplasms
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Glioma
2
Carcinoma, Renal Cell
2
von Hippel-Lindau Disease
1
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Unilateral Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Interventions
Radiosurgery
7
Temozolomide
6
pembrolizumab
4
Magnetic Resonance Spectroscopy
4
Bevacizumab
4
Specimen Handling
3
Nivolumab
3
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Receptors, Interleukin-8B
2
Radiation
2
Mental Status and Dementia Tests
2
Memantine
2
Ipilimumab
2
Biopsy
2
vorasidenib
1
sotorasib
1
sapanisertib
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
encorafenib
1
elacestrant
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brivaracetam
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
palbociclib
×
30 days
×
Clear all
No trials found.